Manufacturer record
Theon Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
26 batches manufactured by Theon Pharmaceuticals Ltd (Himachal Pradesh) were declared Not of Standard Quality between February 2019 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
26 records linked to Theon Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
26Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
26
NSQ batches since 2019
16
Products affected
Description
Most common failure
Dec 2025
Latest alert
Flagged batches per year
2019 · 32020 · 22021 · 42022 · 72023 · 12024 · 12025 · 8
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Olmesartan Medoxomil Tablets IP 20mg | GT250287Mfg 2025-02 · Exp 2027-01 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL Thiruvananthapuram,KeralaState lab | Dec 2025 |
| Montelukast Sodium & Levocetirizine Hydrochloride Dispersible Tablets, (CIVIKAST-LC KID) | GT240841Mfg 2024-04 · Exp 2026-03 | The sample does not conform to Schedule V of Drugs Rules 1940 with respect to the test Disintegration as per IPDisintegration | DTL Thrissur,KeralaState lab | Dec 2025 |
| Clopidogrel & Aspirin Tablets IP | GT250518Mfg 2025-03 · Exp 2027-02 | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab | Dec 2025 |
| Clopidogrel & Aspirin Tablets IP | GT250519Mfg 2025-03 · Exp 2027-02 | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab | Dec 2025 |
| Clopidogrel & Aspirin Tablets IP(75mg/75mg) | GT250375Mfg 2025-02 · Exp 2027-01 | The sample does not conform to IP Standards with respect to Related Substances of Aspirin and Description.Description | DTL ThrissurState lab | Nov 2025 |
| Clopidogrel and Aspirin Tablets IP . | GT241285Mfg 2024-07 · Exp 2026-06 | sample is not of standard quality with respect to the reason stated under 'Description'.Description | CDTL, IndoreCDSCO lab | Sep 2025 |
| Clopidogrel & Aspirin Tablets IP (75mg/75mg) | GT241286Mfg 2024-07 · Exp 2026-06 | sample is not of standard quality with respect to the reason stated under 'Description'.Description | CDTL, IndoreCDSCO lab | Sep 2025 |
| Clopidogrel & Aspirin Tablets (75 mg/ 75 mg) | GT241288Mfg 2024-07 · Exp 2026-06 | DescriptionDescription | CDTL-MumbaiCDSCO lab | May 2025 |
| cefixime Dispersible Tablets IP 100mg | CT240783Mfg 2024-07 · Exp 2026-06 | Assay & DisintegrationAssay | SDTL Agartala, TripuraState lab | Oct 2024 |
| Olmesartan Medoxomil Tablets IP 40 mg | GT22183 1Mfg 2022-10 · Exp 2024-09 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jul 2023 |
| THIOCOLCHICOSI DE CAPSULES IP 4 mg | GC210614Mfg 2021-09 · Exp 2023-08 | AssayAssay | RDTL ChandigarhCDSCO lab | Sep 2022 |
| Theozole (Itraconazole Capsules BP 100 mg) | GC210453Mfg 2021-06 · Exp 2023-05 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Aug 2022 |
| FEXOFENADINE HYDROCHLORIDE TABLETS I.P. | GT211107Mfg 2021-06 · Exp 2023-05 | DissolutionDissolution | CDTL HyderabadCDSCO lab | Jul 2022 |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets | GT201572Mfg 2020-11 · Exp 2022-10 | Description Length Thickness and WidthDescription | CDTL MumbaiCDSCO lab | Mar 2022 |
| Telione - 40 (Telmisartan Tablets IP) | THG210385Mfg 2021-07 · Exp 2023-06 | Uniformity of weightUniformity of weight/content | CDTL MumbaiCDSCO lab | Mar 2022 |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets | GT200466Mfg 2020-03 · Exp 2022-02 | Description & DisintegrationDescription | CDL KolkataCDSCO lab | Feb 2022 |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets | GT200466Mfg 2020-03 · Exp 2022-02 | Description & DisintegrationDescription | RDTL GuwahatiCDSCO lab | Jan 2022 |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets | GT200466Mfg 2020-03 · Exp 2022-02 | DescriptionDescription | RDTL GuwahatiCDSCO lab | Dec 2021 |
| Pregabalin Capsules IP | GC210322Mfg 2021-05 · Exp 2023-04 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Oct 2021 |
| Linezolid Tablets IP | GT200808Mfg 2020-06 · Exp 2022-05 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jul 2021 |
| Theopenam -1g (Meropenem Injection I.P.) | MERM19015AMfg 2019-07 · Exp 2021-06 | Particulate Matter and Clarity of SolutionParticulate matter | CDL KolkataCDSCO lab | Feb 2021 |
| Linezolid Tablets I.P. 600 mg | GT200228Mfg 2020-02 · Exp 2022-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Oct 2020 |
| THEOIMMUNE (Pro-Biotic Capsules) | GC190060Mfg 2019-02 · Exp 2021-01 | Assay of Streptococus faecalis, Clostridium butyricum, Bacillus mesentericus, and Lactic Acid bacillusAssay | CDL KolkataCDSCO lab | Jan 2020 |
| Amoxycillin & Potassium Clavulanate Tablets I.P. 1000 mg | BT 180322Mfg 2018-05 · Exp 2020-04 | Uniformity of Content & DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2019 |
| Lookast-LC (Montelukast Sodium &Levocetrizine Hydrochloride Tablets I.P.) | GT180886Mfg 2018-07 · Exp 2020-06 | Dissolution of Montelukast SodiumDissolution | CDL KolkataCDSCO lab | Mar 2019 |
| Ceftriaxone & Tazobactam For Injection (VEGACEF-TZ) | CFTN17008FMfg 2017-04 · Exp 2019-03 | Particulate ContaminationParticulate matter | Drugs Control Department, MizoramCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.